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Introduction
The incidence and prevalence of pre-malignant and malignant skin lesions have been alarmingly increasing worldwide, creating a major medical and economic problems. Squamous cell carcinomas (SCCs) in particular, have rapidly increased in incidence during the past several decades [1] . DNA [2] . SCC is the most common skin neoplasia and may affect as much as 30-58% of transplanted recipients, usually exhibiting an aggressive course with metastasis [3] . Actinic keratosis, which can eventually develop into invasive SCC, also exhibits an increased incidence in the OTR patients [3] . Therefore, prevention and management of skin cancer in OTR patients become a priority in the field of dermatology and oncology.
damage, gene mutations and various chemicals have all been implicated as etiologic factors in the development of SCC. In addition, solid organ transplant recipients (OTR) are a susceptible population due to the long-term immunosuppressant therapy
Retinoids are the structural and functional analogues of vitamin A with a wide range of biologic activities. Retinoids are active in most tissues and have major impacts on both normal and diseased skin [4] . Systemic retinoids, specifically acitretin, are effective, therapeutic and chemopreventive agents for some non-melanoma skin cancers. Lebwohl et al. [5] described a psoriatic patient developed multiple SCCs after long-term treatment with psoralen plus ultraviolet A and oral acitretin was administered to prevent the recurrence of skin cancer after surgical removal. Kuan et al. [6] successfully treated a patient who had multiple, extensive verrucous carcinomas with a single regimen of acitretin. Acitretin have also shown to be effective in controlling and reducing actinic keratosis [3] and preventing the development of SCC in OTR [2, 7] . [8] [9] [10] . Other hypotheses postulate that retinoids may affect growth factors, down-regulate proto-oncogenes and increase ceramides [11] [12] [13] . Apoptosis plays a critical role in carcinogenesis, its signalling pathways include death receptor (extrinsic) and mitochondrial (intrinsic) pathway [14] 
Acitretin induces apoptosis through CD95 signalling pathway in human cutaneous squamous cell carcinoma cell line SCL-1

Materials and methods
Antibodies and reagents
Antibodies to caspase-3 (sc-7272) 
Cell culture and acitretin treatment
SCL-1, a human SCC cell line [21, 22] , as well as HaCaT, a spontaneously immortalized human keratinocyte cell line [22, 23] 
Real-time PCR analysis
Assays for Fas
Effects of acitretin on apoptosis in SCL-1 cells
Effects of acitretin treatment on caspase activation
Since caspases play a pivotal role in the apoptosis signalling pathway [24, 25] (Fig. 5, Table 1 ). Fig. 6 
did not exert any effect on the apoptosis of SCL-1 cells. However, combined treatment with inhibitor of caspase-8 effectively blocked acitretin-induced apoptosis in SCL-1 cells, whereas with inhibitor of caspase-9 failed to do so (Fig. 3B). These results indicate that acitretin-induced apoptosis is dependent on the activation of caspase-8.
Induction of cell surface Fas protein and mRNA expressions of Fas/FasL during acitretin-induced apoptosis
The fact that caspase-8 inhibitor was found to block acitretininduced apoptosis dramatically in SCL-1 cells encourage us to further investigate whether the cell surface Fas receptor is affected by acitretin with flow cytometric analysis using an anti-Fas monoclonal antibody. The results revealed that the level of the cell surface Fas receptor was significantly increased in acitretin-treated cells compared with the untreated controls (Fig. 4). Accordingly, the results with relative quantification analysis also demonstrated that both Fas and FasL mRNAs increased at 12 hrs after the addition of acitretin and continued to increase substantially in a timedependent manner
Effects of acitretin on protein expressions in Fas apoptotic signalling pathway
To be sure whether acitretin affects the death receptor apoptotic pathway, we checked the status of Fas, FasL and FADD proteins. The results shown in
demonstrate the significantly increased levels of Fas, FasL, FADD in a time-dependent manner
Fig. 1 Effects of acitretin on cell growth of SCL-1 cells. (A) SCL-1 cells and HaCaT cells were treated with acitretin at five different concentrations for 3 days. (B) SCL-1 cells and HaCaT cells were treated with 10 Ϫ5 M of acitretin for various times. Cell proliferation was assessed by MTT assay. Cell viability was estimated from the equation: % of cell viability ϭ 100 ϫ At/Ac, where At and Ac are the absorbencies in treated and control cultures, respectively. Data are shown as median of three different independent experiments (each with three cultures).
just after 12 hrs exposing to acitretin, and these changes were well matched to the appearance of the active caspase-8 fragment (Fig. 3A) , [25, 26, 27] , the involvement of caspases was examined. Among the caspases, caspases-3, -8 and -9 have been shown to play important roles in apoptosis [28] , and caspase-3 is a key executioner involved in apoptosis. Caspase-3 activity is controlled by upstream regulators, such as caspase-9 or caspase-8, which modulates the mitochondria-and death receptor-dependent pathway, respectively [29] . Acitretin activated caspases-3, -8 and -9, it is plausible that both the mitochondrial and the death receptor pathways might be activated by acitretin. However, in our study, the inhibitor of caspase-9 had no significant effect on acitretin-induced apoptosis, indicating that intrinsic pathway did not play the major role in the apoptosis. Caspase-8 inhibitor effectively suppressed acitretin-induced apoptosis, implying that acitretin-induced apoptosis is dependent on the extrinsic pathway because caspase-8 is primarily activated during the death receptor apoptotic pathway. To determine whether the (Fig. 3A) In CD95/CD95L apoptotic signalling, the mitochondrial activation-mediated pathway is required in type II cells [30, 31] . Activation of caspase-8 induces the release of cytochrome c from the mitochondria [18] . Cytochrome c, with the help of apoptotic protease activating factor-1, activates caspase-9 and in turn activates caspase-3 [32] , which is also transmitted in type I cells [33] [7, 37, 38] . For instance, Bavinck et al. [39] 
presumably as a result of Fas/FasL binding. The results indicated that acitretin increased the levels of both Fas and FasL, which could initiate death signalling. To further test this possibility, we examined the effects of ZB4, an antagonistic Fas-antibody, on apoptosis in acitretin-treated cells by disturbing Fas-FasL interaction. As shown Fig. 7, ZB4 alone did not exert any effect on the
Fig. 2 Effects of acitretin on apoptosis in SCL-1 cells. (A) SCL-1 cells and HaCaT cells were treated with acitretin at five different concentrations for 3 days. (B) SCL-1 cells and HaCaT cells were treated with 10
death receptor pathway is really involved in acitretin-induced apoptosis, we evaluated the status of the cell surface Fas receptor, which is a representative member of the death receptor family, is affected by acitretin-treated cells. Interestingly, the expression of Fas on the plasma membrane was significantly increased 48 hrs after acitretin treatment. Corresponding to the appearance of the active caspase-8 fragment
